تحميل
NASDAQHealthcareBiotechnology
أحدث البيانات المتاحة
2.605 US$
−0.025 US$ · -0.95%
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulates cellular metabolism; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceutical-grade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products. In addition, it commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient under NIAGEN brand name. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and authorized healthcare practitioners resellers. The company was formerly known as ChromaDex Corporation and changed its name to Niagen Bioscience, Inc. in March 2025. Niagen Bioscience, Inc. was founded in 1999 and is headquartered in Los Angeles, California.
جلسة التداول العادية
2.605 US$
−0.025 US$ · -0.95%
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulates cellular metabolism; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceutical-grade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products. In addition, it commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient under NIAGEN brand name. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and authorized healthcare practitioners resellers. The company was formerly known as ChromaDex Corporation and changed its name to Niagen Bioscience, Inc. in March 2025. Niagen Bioscience, Inc. was founded in 1999 and is headquartered in Los Angeles, California.
نطاق اليوم
السعر الحالي 2.605 US$
نطاق 52 أسبوعًا
السعر الحالي 2.605 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
احتفاظ
تقييم
91
قيمة جذابة جدًا
المشاعر
65
صعودي
المخاطر
71
مخاطر مرتفعة
الزخم
20
هبوط قوي
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulates cellular metabolism; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceutical-grade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products. In addition, it commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient under NIAGEN brand name. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and authorized healthcare practitioners resellers. The company was formerly known as ChromaDex Corporation and changed its name to Niagen Bioscience, Inc. in March 2025. Niagen Bioscience, Inc. was founded in 1999 and is headquartered in Los Angeles, California.
نطاق اليوم
السعر الحالي 2.605 US$
نطاق 52 أسبوعًا
السعر الحالي 2.605 US$
النتائج المعلنة مع توقعات الإجماع المتاحة.
النتائج المعلنة مع توقعات الإجماع المتاحة.
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
متوسط الهدف
10.33 US$
ارتفاع محتمل بنسبة 296.55%صناديق متداولة تفصح عن تعرضها لهذا السهم.
Gabelli Love Our Planet & People ETFLOPP5.8 مليون0.39%14.7 مليون USD0.90%35.63 US$-0.43%
Vanguard Morningstar Total Stock Market ETFVTI4.6 مليون0.00%2.3 ترليون USD0.03%380.9 US$-0.18%
iShares Russell 2000 ETFIWM3.9 مليون0.01%78.74 مليار USD0.19%276.2 US$-0.61%
Vanguard Extended Market ETFVXF2.06 مليون0.00%95.4 مليار USD0.05%232.08 US$-0.62%
Vanguard Consumer Staples ETFVDC1.86 مليون0.02%9.3 مليار USD0.09%228.9 US$0.00%
iShares Russell 2000 Growth ETFIWO1.42 مليون0.01%13.92 مليار USD0.24%350.9 US$-0.80%
Vanguard Russell 2000 ETFVTWO1.04 مليون0.01%18 مليار USD0.06%111.56 US$-0.64%
Schwab U.S. Small-Cap ETFSCHA793.95 ألف0.00%21.71 مليار USD0.03%32.485 US$-0.54%Gabelli Love Our Planet & People ETFLOPPVanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFVanguard Consumer Staples ETFVDCiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWOSchwab U.S. Small-Cap ETFSCHAالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.
